We conducted comparisons between plasma p-tau of the blood-based biomarker for DS-AD and DSQIID total/sub-item scores, which is a structured caregiver interview specifically asking about functional and behavioral changes and is believed to be an appropriate screening tool for detecting dementia in DS. This evidence concerns the gene MAPT and Alzheimer disease.